ANAPROX
LIVE

Serial Number

98576017

Owner

Atnahs Pharma UK Limited

Attorney

Michael J. Thomas

Filing Date

May 30, 2024

Add to watchlist:

No watchlists yet
View on USPTO

ANAPROX Trademark

Serial Number: 98576017 • Registration: 8182786

ANAPROX is a trademark filed by Atnahs Pharma UK Limited on May 30, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Atnahs Pharma UK Limited (5 trademarks)

Sovereign House, Miles Gray Road,

Entity Type: 99

Trademark Details

Filing Date

May 30, 2024

Registration Date

March 24, 2026

Goods & Services

Analgesics; Analgesic preparations; anti-inflammatory preparations.

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 24, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 24, 2026 R.PR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Dec 19, 2025 ERRR
NOTICE OF ALLOWANCE CANCELLED
Dec 16, 2025 IUCN
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Dec 2, 2025 JURT
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Dec 2, 2025 PCBG
ASSIGNED TO PETITION STAFF
Dec 2, 2025 APET
TEAS PETITION TO AMEND BASIS RECEIVED
Oct 24, 2025 TPAD
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 16, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 22, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jul 22, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 16, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 16, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 3, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 3, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 3, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Mar 11, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Mar 11, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 12, 2024 GNRN
NON-FINAL ACTION E-MAILED
Dec 12, 2024 GNRT
NON-FINAL ACTION WRITTEN
Dec 12, 2024 CNRT
ASSIGNED TO EXAMINER
Dec 12, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 14, 2024 NWOS
NEW APPLICATION ENTERED
May 30, 2024 NWAP